Inhibikase Therapeutics, Inc. · NASDAQ:IKT

ADAR1 Capital Management, LLC reported a 9.90% stake in Inhibikase Therapeutics, Inc. (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 15, 2026

ADAR1 Capital Management, LLC reported a 9.90% stake in Inhibikase Therapeutics, Inc., 13,860,028 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
13,860,028
Intent
Passive
What changed
Stake changed
Filed together
3 holders

The filing in full

HolderStakeShares
ADAR1 Capital Management, LLC9.90%13,860,028
ADAR1 Capital Management GP, LLC8.50%11,832,998
Daniel Schneeberger9.90%13,860,028

Source

View original at SEC

Related